Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - PROGENICS PHARMACEUTICALS INC | form10_k12312015.htm |
| EX-31.2 - EXHIBIT 31.2 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex31_212312015.htm |
| EX-31.1 - EXHIBIT 31.1 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex31_112312015.htm |
| EX-23.1 - EXHIBIT 23.1 CONSENT OF ERNST & YOUNG LLP - PROGENICS PHARMACEUTICALS INC | ex23_112312015.htm |
| EX-32.2 - EXHIBIT 32.2 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex32_212312015.htm |
| EX-32.1 - EXHIBIT 32.1 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex32_112312015.htm |
| EX-10.48 - EXHIBIT 10.48 - PROGENICS PHARMACEUTICALS INC | ex10_4812312015.htm |
| EX-10.47 - EXHIBIT 10.47 - PROGENICS PHARMACEUTICALS INC | ex10_4712312015.htm |
| EX-10.49 - EXHIBIT 10.49 - PROGENICS PHARMACEUTICALS INC | ex10_4912312015.htm |
| EX-21.1 - EXHIBIT 21.1 SUBSIDIARIES OF PROGENICS PHARMACEUTICALS, INC. - PROGENICS PHARMACEUTICALS INC | ex21_112312015.htm |
Exhibit 12.1
Progenics Pharmaceuticals, Inc.
Ratio of (Loss) Earnings to Combined Fixed Charges and Preferred Stock Dividends
(in thousands)
|
|
Years Ended December 31,
|
|||||||||||||||||||
|
|
2015
|
2014
|
2013
|
2012
|
2011
|
|||||||||||||||
|
Determination of (loss) earnings:
|
||||||||||||||||||||
|
(Loss) income from operations
|
$
|
(39,119
|
)
|
$
|
4,410
|
|
$
|
(42,934
|
) |
$
|
(35,431
|
)
|
$
|
10,381
|
|
|||||
|
Add:
|
||||||||||||||||||||
|
Fixed charges
|
373
|
373
|
710
|
410
|
695
|
|||||||||||||||
|
|
||||||||||||||||||||
|
(Loss) earnings, as adjusted
|
$
|
(38,746
|
)
|
$
|
4,783
|
|
$
|
(42,224
|
) |
$
|
(35,021
|
)
|
$
|
11,076
|
|
|||||
|
|
||||||||||||||||||||
|
Fixed charges:
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
Estimate of interest within rental expense
|
373
|
373
|
710
|
410
|
695
|
|||||||||||||||
|
|
||||||||||||||||||||
|
Fixed charges
|
$
|
373
|
$
|
373
|
$
|
710
|
$
|
410
|
$
|
695
|
||||||||||
|
|
||||||||||||||||||||
|
Preferred stock dividends
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
||||||||||
|
|
||||||||||||||||||||
|
Ratio of (loss) earnings to fixed charges and preferred stock dividends
|
*
|
13
|
*
|
*
|
16
|
|||||||||||||||
|
Coverage deficiency amount for total fixed charges and preferred stock dividends (1)
|
$
|
39,119
|
$
|
-
|
$
|
42,934
|
$
|
35,431
|
$
|
-
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
For the years ended 2012, 2013 and 2015, the Company's coverage ratio is less than one-to-one and it must generate additional earnings of these specified amounts to achieve a coverage ratio of 1:1.
|
|
||||||||||||||||||